— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$141M +9.8% ▲
5Y CAGR: -24.9%
Gross Profit
$48M +18.3% ▲
5Y CAGR: -8.7%
Operating Income
$1M +103.3% ▲
Net Income
-$26M +32.7% ▲
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
$1M +104.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2024FY2025FY2026
Revenue$544M$186M$128M$129M$141M
YoY Growth-7.8%-65.9%+0.0%+0.5%+9.8%
Cost of Revenue$463M$135M$86M$89M$94M
Gross Profit$81M$50M$42M$40M$48M
Gross Margin15.0%27.1%32.6%31.3%33.7%
R&D Expenses$10M$8M$9M$8M$9M
SG&A Expenses$65M$46M$40M$44M$33M
Operating Expenses$76M$54M$49M$52M$41M
Operating Income-$25M-$86M$9M-$39M$1M
Operating Margin-4.6%-46.2%7.3%-30.0%0.9%
Interest Expense$15M$17M-$3M$3M-$2M
Income Before Tax-$40M-$52M$10M-$39M-$26M
Tax Expense-$8M-$6M-$183K$43K-$362K
Net Income-$33M-$46M$12M-$39M-$26M
Net Margin-6.0%-24.9%9.4%-30.0%-18.4%
EPS (Diluted)$-1.11$-1.57$0.25$-1.13$0.00
EBITDA-$17M-$46M$9M-$39M$1M
Shares Outstanding29M29M37M34M0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms